Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 23.07B | 24.22B | 28.57B | 38.37B | 24.53B | 13.69B |
Gross Profit | 7.34B | 8.65B | 7.92B | 6.69B | 6.34B | 3.47B |
EBITDA | 8.32B | 10.68B | 8.05B | 3.83B | 4.43B | 4.63B |
Net Income | 2.58B | 5.13B | 1.45B | 2.72B | 721.00M | 1.05B |
Balance Sheet | ||||||
Total Assets | 97.81B | 98.44B | 106.49B | 138.55B | 142.31B | 61.67B |
Cash, Cash Equivalents and Short-Term Investments | 9.27B | 11.94B | 14.64B | 20.46B | 13.87B | 8.99B |
Total Debt | 20.26B | 15.79B | 13.67B | 15.62B | 12.11B | 3.35B |
Total Liabilities | 61.25B | 64.82B | 73.35B | 109.27B | 125.31B | 43.70B |
Stockholders Equity | 33.05B | 31.55B | 31.57B | 27.58B | 15.25B | 17.18B |
Cash Flow | ||||||
Free Cash Flow | -5.86B | -2.76B | -923.00M | -2.08B | 3.58B | 817.00M |
Operating Cash Flow | 5.03B | 6.62B | 4.24B | 2.41B | 7.27B | 4.17B |
Investing Cash Flow | -11.26B | -9.71B | -2.81B | -9.89B | -7.74B | -4.35B |
Financing Cash Flow | 4.13B | 1.12B | -1.56B | 8.62B | 1.46B | 1.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | €2.00B | 13.04 | 8.40% | 4.13% | -11.39% | -4.89% | |
63 Neutral | €28.20B | 10.84 | 7.90% | 2.90% | -7.36% | -25.03% | |
60 Neutral | €41.95B | 13.32 | 18.06% | 3.43% | 1.60% | 76.73% | |
60 Neutral | €21.34B | 51.00 | 12.15% | 2.30% | -10.30% | 0.96% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% |